SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Mar-24 4:06 PM View: | Alx Oncology Holdings Inc (ALXO) | 14-Mar-24 | Private Purchase | 4,400 | $11.31 | $49,771.50 | 3% 167.22K to 171.62K | |
16-Feb-24 6:03 PM View: | Alx Oncology Holdings Inc (ALXO) | 14-Feb-24 | Grant | 60,000 | -- | -- | 56% 107.22K to 167.22K | |
15-Dec-21 9:48 PM View: | Alx Oncology Holdings Inc (ALXO) | 13-Dec-21 | Market Sale | 325,377 | $27.36 | $8,901,800.00 | (7%) 4.96M to 4.63M | 12% |
10-Dec-21 9:22 PM View: | Alx Oncology Holdings Inc (ALXO) | 10-Dec-21 | Market Sale Duplicate | 26,274 | $31.31 | $822,719.00 | (< 1%) 5.0M to 4.98M | 1% |
10-Dec-21 9:22 PM View: | Alx Oncology Holdings Inc (ALXO) | 09-Dec-21 | Market Sale Duplicate | 76,905 | $32.03 | $2,463,500.00 | (2%) 5.08M to 5.0M | 3% |
10-Dec-21 9:22 PM View: | Alx Oncology Holdings Inc (ALXO) | 08-Dec-21 | Market Sale Duplicate | 42,458 | $33.25 | $1,411,870.00 | (< 1%) 5.12M to 5.08M | 7% |
21-Jul-20 9:31 PM View: | Alx Oncology Holdings Inc (ALXO) | 21-Jul-20 | Conversion | 88,704 | -- | -- | 14% 648.34K to 737.04K | |
21-Jul-20 9:31 PM View: | Alx Oncology Holdings Inc (ALXO) | 21-Jul-20 | Conversion | 3,691,170 | -- | -- | 501% 737.04K to 4.43M | |
21-Jul-20 9:31 PM View: | Alx Oncology Holdings Inc (ALXO) | 21-Jul-20 | Purchase | 400,000 | $19.00 | $7,600,000.00 | 9% 4.43M to 4.83M | |
31-Oct-16 4:51 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Conversion | 3,592,760 | -- | -- | 45% 8.0M to 11.6M | |
31-Oct-16 4:51 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Purchase | 393,923 | $13.00 | $5,121,000.00 | 3% 11.6M to 11.99M | |
31-Oct-16 4:51 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Sale Duplicate | 340 | $13.00 | $4,420.00 | (< 1%) 12.05M to 12.05M | |
31-Oct-16 4:51 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 31-Oct-16 | Exercise (in-the money or at-the-money) Duplicate | 63,019 | $0.07 | $4,411.33 | < 1% 11.99M to 12.05M |